Treatment of mastalgia and mastodynia in peri-and postmenopause


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To define alternative therapies allowing better quality of life in peri- and postmenopausal women with the signs of mastalgia and mastodynia. Subjects and methods. This investigation was based on the information available in the medical records and control follow-up charts of 475peri- and postmenopausal women with mastalgia and mastodynia, and in 30% with f ibrocystic mastopathy, whose examination and combination treatment had been performed in the consulting diagnostic polyclinic of the Yekaterinburg City Clinical Hospital Forty in the period 1997 to 2010. Results. The complete or partial resolution rate for the symptoms of mastodynia was 85.9% in the examinees. Conclusion. The findings confirmed the possibility of effective use of mastodynon in therapy of mastalgia and mastodynia in peri- and postmenopausal women.

Full Text

Restricted Access

About the authors

Geljus Harisovich Khanafiev

40th Clinical City Hospital

Email: hanafievgh@mail.ru
MD, PhD, mammologist, out-patient Consultaion and Diagnostic office Ekaterinburg

References

  1. Семиглазов В.Ф., Веснин А.Г., Моисеенко В.М. Минимальный рак молочной железы (профилактика, выявление, лечение). СПб.: Гиппократ; 1992. 240 с. [Semiglazov V.F., Vesnin A.G., Moiseenko V.M. Minimal cancer of mammary glands (prophylactics, screening, treatment). SPb: Hippocrat; 1992. 240 p. In Russ.]
  2. Семиглазов В.Ф. Мастопатия - угроза малигнизации? Terra Medica Nova. 2005; 2: 52-6. [Semiglazov V.F. Mastopathy - the treat of malignization? Terra Medica Nova. 2005; 2: 52-56. In Russ.]
  3. Jatoi Ismail, Kaufmann M., eds. Management of breast diseases. New York: Springer; 2009. 671 р.
  4. Седаков И.Е., Александров А.И., Денисенко Я.В., Ищенко Р.В. Опыт лечения при мастопатии у женщин в менопаузе. Жшочий лгкар. 2007; 1: 8-18. [Sedakov I.E., Alexandrov A.I., Denisenko Ya.V., Ischenko R.V. Experience of the treatment of mastopathy in women in menopause. Isoci lger. 2007; 1: 8-18. In Russ.]
  5. Летягин В.П. Мастопатия. Русский медицинский журнал. 2000; 11: 468-73. [Letyagin V.P. Mastopathy. Russian Medical journal. 2000; 11: 23-31. In Russ.]
  6. Бурдина И.И. Возможности фитотерапии в лечении доброкачественных заболеваний молочной железы. Репродуктивное здоровье женщины. 2005; 2: 124-6. [Burdina I.I. Possibilities of phytotherapy in treatment of benign diseases of mammary glands. Reproductivnoe zdorovie zhenschini. 2005; 2: 124-6. In Russ.]
  7. Макаренко Н.П. Мастопатия. Русский медицинский журнал. 1999; 10: 451-4. [Makarenko N.P. Mastopathy. Russian Medical journal. 1999; 10: 9-11. In Russ.]
  8. Oldenhave A., Jaszmann L.J., Haspels A.A., Everaerd W.T. Impact of climacteric on well-being. A survey based on 5213 women from 39 to 60 years old. Am. J. Obstet. Gynecol. 1993; 168(3, Pt 1): 772-80.
  9. Огнерубов Н.А., Кушлинский Н.Е., Ткачева И.А. Клинические и эндокринологические исследования при мастопатии и раке молочной железы. Воронеж: Истоки; 1998. 176 с. [Ognerubov N.A., Kushlinsky N.E., Tkacheva I.A. Clinical and endocrinological studies with mastopathy and cancer of the mammary glands. Voronezh: Istoki; 1998. 176 p. In Russ.]
  10. Wuttke W., Jarry H., Becker T., Schultens A., Christoffel V., Gorkow C., Seidlovd-Wuttke D. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas. 2003; 44(Suppl. 1): S9-20.
  11. Seidlovd-Wuttke D., Jarry H., Becker T., Christoffel V., Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas. 2003; 44(Suppl. 1): S39-50.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies